Plain-English translation of NCT04604782 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1/2 โ A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a medication called in children and infants to see if it is safe and how their bodies handle it. is used to stress the heart during a special imaging test (called a CMR scan) that helps doctors see how well blood is flowing to the heart. Right now, this medication is used in adults, but doctors need to learn if it works safely in younger patients.
Children and infants sometimes need special heart imaging tests to check for heart problems, but the medication used to stress the heart during these tests hasn't been properly studied in young patients. This trial will help doctors understand the right dose and safety profile of this medication for children of different ages.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Your child will visit one of about 10 study centers in Europe for a single visit. During this visit, the medication will be given once while your child's heart is being monitored, and a heart imaging scan (CMR) will be performed to see how the medication affects blood flow to the heart. Depending on your child's age, sedation or general anesthesia may be used to keep them comfortable during the scan. The study team will monitor your child closely during and after the procedure to make sure the medication is safe.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
France
Greece
Italy
United Kingdom